340 related articles for article (PubMed ID: 34090477)
41. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.
Milovanovic M; Volarevic V; Ljujic B; Radosavljevic G; Jovanovic I; Arsenijevic N; Lukic ML
PLoS One; 2012; 7(9):e45225. PubMed ID: 23028861
[TBL] [Abstract][Full Text] [Related]
42. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
Nam Y; Kim JH; Seo M; Kim JH; Jin M; Jeon S; Seo JW; Lee WH; Bing SJ; Jee Y; Lee WK; Park DH; Kook H; Suk K
J Biol Chem; 2014 Jun; 289(24):16773-89. PubMed ID: 24808182
[TBL] [Abstract][Full Text] [Related]
43. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.
Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E
Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483
[TBL] [Abstract][Full Text] [Related]
44. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
[TBL] [Abstract][Full Text] [Related]
45. Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice.
Fernando V; Omura S; Sato F; Kawai E; Martinez NE; Elliott SF; Yoh K; Takahashi S; Tsunoda I
Int J Mol Sci; 2014 Jan; 15(2):1700-18. PubMed ID: 24463292
[TBL] [Abstract][Full Text] [Related]
46. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
47. The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis.
Kamizato K; Sato S; Shil SK; Umaru BA; Kagawa Y; Yamamoto Y; Ogata M; Yasumoto Y; Okuyama Y; Ishii N; Owada Y; Miyazaki H
Neuroscience; 2019 Jun; 409():120-129. PubMed ID: 31051217
[TBL] [Abstract][Full Text] [Related]
48. Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitis.
Rossetti I; Zambusi L; Finardi A; Bodini A; Provini L; Furlan R; Morara S
J Neuroimmunol; 2018 Oct; 323():94-104. PubMed ID: 30196840
[TBL] [Abstract][Full Text] [Related]
49. Potential of Adult Endogenous Neural Stem/Progenitor Cells in the Spinal Cord to Contribute to Remyelination in Experimental Autoimmune Encephalomyelitis.
Maeda Y; Nakagomi N; Nakano-Doi A; Ishikawa H; Tatsumi Y; Bando Y; Yoshikawa H; Matsuyama T; Gomi F; Nakagomi T
Cells; 2019 Sep; 8(9):. PubMed ID: 31484369
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis.
Prins M; Eriksson C; Wierinckx A; Bol JG; Binnekade R; Tilders FJ; Van Dam AM
PLoS One; 2013; 8(12):e83835. PubMed ID: 24376764
[TBL] [Abstract][Full Text] [Related]
51. Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis.
Gerzanich V; Makar TK; Guda PR; Kwon MS; Stokum JA; Woo SK; Ivanova S; Ivanov A; Mehta RI; Morris AB; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2017 Sep; 14(1):177. PubMed ID: 28865458
[TBL] [Abstract][Full Text] [Related]
52. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
[TBL] [Abstract][Full Text] [Related]
53. Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.
Borjini N; Fernández M; Giardino L; Calzà L
J Neuroinflammation; 2016 Nov; 13(1):291. PubMed ID: 27846891
[TBL] [Abstract][Full Text] [Related]
54. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
[TBL] [Abstract][Full Text] [Related]
55. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
56. Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis.
van Loo G; Sze M; Bougarne N; Praet J; Mc Guire C; Ullrich A; Haegeman G; Prinz M; Beyaert R; De Bosscher K
Mol Endocrinol; 2010 Feb; 24(2):310-22. PubMed ID: 19965930
[TBL] [Abstract][Full Text] [Related]
57. Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.
Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Fakour M; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Tashakori-Miyanroudi M; Roghani M
J Mol Neurosci; 2021 Feb; 71(2):215-224. PubMed ID: 32812186
[TBL] [Abstract][Full Text] [Related]
58. Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Valero-Esquitino V; Lucht K; Namsolleck P; Monnet-Tschudi F; Stubbe T; Lucht F; Liu M; Ebner F; Brandt C; Danyel LA; Villela DC; Paulis L; Thoene-Reineke C; Dahlöf B; Hallberg A; Unger T; Sumners C; Steckelings UM
Clin Sci (Lond); 2015 Jan; 128(2):95-109. PubMed ID: 25052203
[TBL] [Abstract][Full Text] [Related]
59. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
[TBL] [Abstract][Full Text] [Related]
60. Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitis.
Gruber RC; Ray AK; Johndrow CT; Guzik H; Burek D; de Frutos PG; Shafit-Zagardo B
J Neurosci; 2014 Dec; 34(49):16320-35. PubMed ID: 25471571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]